HER2 Support Group Forums - View Single Post - Dr. Spector at ASCO and Lapatinib Sucess...

Lani · 06-04-2006, 01:05 PM

I actually hold some personal doubts that IBC is truly different from IDC. In the future, I think, the histological appearance of a breast cancer will be the last thing considered in how to treat it. Nevertheless, IBC has been described as having a different natural history and response/nonresponse to treatments than IDC (as far as they now know, which is not that far). I just urge caution in drawing conclusions...it will be interesting to see what genetic profile group IDC eventually gets thrown into, or whether it will have its own like basal-like, her2, luminal A, luminal B, etc.

06-04-2006, 01:05 PM	#4
Lani Senior Member Join Date: Mar 2006 Posts: 4,783	Robin I actually hold some personal doubts that IBC is truly different from IDC. In the future, I think, the histological appearance of a breast cancer will be the last thing considered in how to treat it. Nevertheless, IBC has been described as having a different natural history and response/nonresponse to treatments than IDC (as far as they now know, which is not that far). I just urge caution in drawing conclusions...it will be interesting to see what genetic profile group IDC eventually gets thrown into, or whether it will have its own like basal-like, her2, luminal A, luminal B, etc.